Repligen | RGEN - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Agilent USD 442M 1000K 2025-09
Align Technology USD 176.6M 81.86M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
BioMarin Pharmaceutical USD -26.32M 324.19M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Bruker USD -72.6M 73.1M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Exact Sciences USD -17.76M 17.7M 2025-09
General Electric Aerospace USD 2.85B 337M 2025-12
Henry Schein USD 137M 16M 2025-09
Illumina USD 220M 86M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 6.2M 2.1M 2024-12
OraSure Technologies USD -234K 3.37M 2024-06
Pacific Biosciences Of California USD -60.72M 112.59M 2024-09
Pfizer USD 3.33B 290M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Standard Biotools USD -32.9M 14.62M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Waters USD 170.12M 7.57M 2025-09
West Pharmaceutical Services USD 170.1M 8.1M 2025-09